Learn how Huntsman Cancer Institute uses cutting‑edge diagnostics and personalized care to treat early‑stage prostate cancer. Discover why early detection makes treatment more effective and far less ...
A gene called FOXJ1 may drive resistance to taxane chemotherapy during treatment for advanced prostate cancer, according to a new study led by investigators at Weill Cornell Medicine and Beth Israel ...
There are different ways to manage fatigue during prostate cancer treatment, including exercise, sleep, complementary ...
Maurice Blake says he never knew that one-in-four black men face prostate cancer - double the average.
Targeted ultrasound therapy offers a less invasive prostate cancer treatment designed to minimize disruption to daily life.
Dr Fred Saad of the University of Montreal discusses the future direction of alpha emitter agents in the treatment of prostate cancer, emphasizing the logical progression of resea ...
Men with prostate cancer are being denied NHS access to a treatment used by Lord Cameron, a senior doctor has revealed.
CURE highlights prostate cancer advancements from Day One of the 2026 ASCO Genitourinary Cancers Symposium.
Incontinence and other urinary problems after prostate cancer treatment can be eased with Kegel exercises, bladder training, ...
Niraparib and abiraterone acetate regimen demonstrates clinically meaningful delay in disease progression, nearly halving the risk of progression or death, with an early trend toward improved overall ...
John Tesh is continuing to battle cancer ten years after doctors gave him 18 months to live. "I was given 18 months to live," the former TV personality told Page Six. "So, I’ve been fighting cancer ...
News-Medical.Net on MSN
FOXJ1 gene may drive resistance to taxane chemotherapy in advanced prostate cancer
A gene called FOXJ1 may drive resistance to taxane chemotherapy during treatment for advanced prostate cancer, according to a new study led by investigators at Weill Cornell Medicine and Beth Israel ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果